New Results
Wild-type Splicing Factor U2AF1 inhibits splicing associated with a recurrent U2AF1 mutant in human lung cancers and is required for cell survival
Dennis Liang Fei, Hayley Motowski, Rakesh Chatrikhi, Sameer Prasad, Jovian Yu, Shaojian Gao, Clara Kielkopf, Robert K. Bradley, Harold Varmus
doi: https://doi.org/10.1101/048553
Dennis Liang Fei
1Cancer Biology Section, Cancer Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892, United States
2Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, United States
Hayley Motowski
1Cancer Biology Section, Cancer Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892, United States
Rakesh Chatrikhi
3Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY 14642, United States
Sameer Prasad
1Cancer Biology Section, Cancer Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892, United States
Jovian Yu
1Cancer Biology Section, Cancer Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892, United States
Shaojian Gao
4Genetics Branch, National Cancer Institute, Bethesda, Maryland, 20892, United States
Clara Kielkopf
3Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY 14642, United States
Robert K. Bradley
5Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States
6Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, United States
Harold Varmus
1Cancer Biology Section, Cancer Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892, United States
2Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, United States
Article usage
Posted April 13, 2016.
Wild-type Splicing Factor U2AF1 inhibits splicing associated with a recurrent U2AF1 mutant in human lung cancers and is required for cell survival
Dennis Liang Fei, Hayley Motowski, Rakesh Chatrikhi, Sameer Prasad, Jovian Yu, Shaojian Gao, Clara Kielkopf, Robert K. Bradley, Harold Varmus
bioRxiv 048553; doi: https://doi.org/10.1101/048553
Wild-type Splicing Factor U2AF1 inhibits splicing associated with a recurrent U2AF1 mutant in human lung cancers and is required for cell survival
Dennis Liang Fei, Hayley Motowski, Rakesh Chatrikhi, Sameer Prasad, Jovian Yu, Shaojian Gao, Clara Kielkopf, Robert K. Bradley, Harold Varmus
bioRxiv 048553; doi: https://doi.org/10.1101/048553
Subject Area
Subject Areas
- Biochemistry (11744)
- Bioengineering (8751)
- Bioinformatics (29193)
- Biophysics (14968)
- Cancer Biology (12094)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18303)
- Genetics (12244)
- Genomics (16801)
- Immunology (11866)
- Microbiology (28082)
- Molecular Biology (11592)
- Neuroscience (60959)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)